|   LifeSciVC

Our 2019 Year In Review: Macro, Biotech, and Atlas

By Bruce Booth, DPhil, Partner

It’s that time of year again when we pause to reflect on the state of the industry – and there’s more to focus on in biopharma today than just the drug pricing debate.

As I described last year, we host two major events in the 4Q every year: our Atlas Venture Annual Meeting for our fund investors (Limited Partners) and our Atlas Retreat for senior industry executives. As a customary kickoff for these events, we share a summary “Year In Review” to frame up some of the important themes facing biopharma.  Last year we shared the 2018 presentation here via a video, and decided to do the same this year.

Read more.